Article

Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients.

United States Army Institute of Surgical Research, Ft Sam Houston, TX 78234, USA.
Annals of surgery (Impact Factor: 7.19). 09/2008; 248(3):447-58. DOI: 10.1097/SLA.0b013e318185a9ad
Source: PubMed

ABSTRACT To determine the effect of blood component ratios in massive transfusion (MT), we hypothesized that increased use of plasma and platelet to red blood cell (RBC) ratios would result in decreased early hemorrhagic death and this benefit would be sustained over the ensuing hospitalization.
Civilian guidelines for massive transfusion (MT > or =10 units of RBC in 24 hours) have typically recommend a 1:3 ratio of plasma:RBC, whereas optimal platelet:RBC ratios are unknown. Conversely, military data shows that a plasma:RBC ratio approaching 1:1 improves long term outcomes in MT combat casualties. There is little consensus on optimal platelet transfusions in either civilian or military practice. At present, the optimal combinations of plasma, platelet, and RBCs for MT in civilian patients is unclear.
Records of 467 MT trauma patients transported from the scene to 16 level 1 trauma centers between July 2005 and June 2006 were reviewed. One patient who died within 30 minutes of admission was excluded. Based on high and low plasma and platelet to RBC ratios, 4 groups were analyzed.
Among 466 MT patients, survival varied by center from 41% to 74%. Mean injury severity score varied by center from 22 to 40; the average of the center means was 33. The plasma:RBC ratio ranged from 0 to 2.89 (mean +/- SD: 0.56 +/- 0.35) and the platelets:RBC ratio ranged from 0 to 2.5 (0.55 +/- 0.50). Plasma and platelet to RBC ratios and injury severity score were predictors of death at 6 hours, 24 hours, and 30 days in multivariate logistic models. Thirty-day survival was increased in patients with high plasma:RBC ratio (> or =1:2) relative to those with low plasma:RBC ratio (<1:2) (low: 40.4% vs. high: 59.6%, P < 0.01). Similarly, 30-day survival was increased in patients with high platelet:RBC ratio (> or =1:2) relative to those with low platelet:RBC ratio (<1:2) (low: 40.1% vs. high: 59.9%, P < 0.01). The combination of high plasma and high platelet to RBC ratios were associated with decreased truncal hemorrhage, increased 6-hour, 24-hour, and 30-day survival, and increased intensive care unit, ventilator, and hospital-free days (P < 0.05), with no change in multiple organ failure deaths. Statistical modeling indicated that a clinical guideline with mean plasma:RBC ratio equal to 1:1 would encompass 98% of patients within the optimal 1:2 ratio.
Current transfusion practices and survival rates of MT patients vary widely among trauma centers. Conventional MT guidelines may underestimate the optimal plasma and platelet to RBC ratios. Survival in civilian MT patients is associated with increased plasma and platelet ratios. Massive transfusion practice guidelines should aim for a 1:1:1 ratio of plasma:platelets:RBCs.

1 Bookmark
 · 
245 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is growing interest in the use of blood components for pre-hospital resuscitation of patients with major traumatic haemorrhage. It has been speculated that early resuscitation with blood components may have benefits in terms of treating trauma-induced coagulopathy, which in turn may influence survival. The proposed systematic review will evaluate the evidence on the clinical effectiveness of pre-hospital blood components (red blood cells and/or plasma or whole blood), in both civilian and military settings, compared with other resuscitation strategies in patients with major traumatic haemorrhage.Methods/design: Standard systematic review methods aimed at minimising bias will be employed for study identification, selection and data extraction. General medical and specialist databases will be searched; the search strategy will combine terms for the population, intervention and setting. Studies will be selected for review if the population includes adult patients with major traumatic haemorrhage who receive blood components in a pre-hospital setting (civilian or military). Systematic reviews, randomised and non-randomised controlled trials and controlled observational studies will be included. Uncontrolled studies will be considered depending on the volume of controlled evidence. Quality assessment will be tailored to different study designs. Both patient related and surrogate outcomes will be considered. Synthesis is likely to be primarily narrative, but meta-analyses and subgroup analyses will be undertaken where clinical and methodological homogeneity exists.
    Systematic reviews. 10/2014; 3(1):123.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Postpartum hemorrhage (PPH) is a leading cause of maternal mortality worldwide. Recent advances in the management of severe bleeding for trauma patients may provide insight into PPH management, but must be applied with caution considering the significant differences between trauma and obstetric patients. In this review, we summarized evidence for current management strategies for patients with major obstetric hemorrhage, including (1) rapid laboratory assessment of coagulopathy, (2) early transfusion of plasma and high plasma-to-red blood cell transfusion ratios in massive PPH, and (3) use of tranexamic acid and fibrinogen concentrates in the setting of PPH complicated by coagulopathy.
    Anesthesia & Analgesia 11/2014; 119(5):1140-1147. · 3.42 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: IntroductionIdentifying patients in need for Damage Control Resuscitation (DCR) early after trauma, is pivotal for adequate management of their critical condition. Several trauma-scoring systems have been developed to identify such patients but most of them are not simple enough to be used in the pre-hospital settings at the early post-traumatic phase. The Trauma Induced Coagulopathy Clinical Score (TICCS) is an easy-to-measure and strictly clinical trauma score developed to meet this medical need.MethodsTICCS is a 3-item clinical score (range 0 to 18) based on the assessment of general severity, blood pressure and extent of body injury and calculated by paramedics on site for patients with severe trauma. This non-interventional prospective study was designed to assess the ability of TICCS to discern patients in need for DCR. These patients were patients with Early Acute Coagulopathy of Trauma (EACT), haemorrhagic shock, massive transfusion (MT) and surgical or endovascular haemostasis during hospitalization. Diagnosis of EACT was assessed by both thromboelastometry and conventional coagulation tests.ResultsDuring 18 months, 89 severe trauma patients admitted to the general emergency unit were enrolled in the study but seven were excluded for protocol violation. Of the 82 patients, eight needed DCR and 74 did not. Using receiver operating characteristic curve analysis, TICCS proved to be a powerful discriminant test (area under the curve =0.98; 95% CI: 0.92 to 1.0). A cut-off of 10 on the TICCS scale provided the best balance between sensitivity (100%; 95%CI: 53.9 to 100) and specificity (95.9%; 95%CI: 88.2 to 99.2). The positive predictive value was 72.7% and the negative predictive value 100.0%.ConclusionTICCS can be easily and rapidly measured on the site of trauma by paramedics. In this study of blunt trauma patients, TICCS was able to discriminate between patients with and without need for DCR. TICCS on-site evaluation should allow initiation of optimal care immediately upon hospital admission of patients with severe trauma in need of DCR. In-depth validation of TICCS though requires a larger multicenter prospective study.Trial registrationclinicaltrials.gov NCT02132208 Registered 6 May 2014.
    Critical care (London, England) 11/2014; 18(6):648. · 5.04 Impact Factor

Full-text (2 Sources)

Download
96 Downloads
Available from
May 16, 2014